Oppenheimer Forecasts Strong Price Appreciation for Corteva (NYSE:CTVA) Stock

Corteva (NYSE:CTVA) had its target price increased by research analysts at Oppenheimer from $86.00 to $89.00 in a note issued to investors on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s target price indicates a potential upside of 11.73% from the company’s previous close.

Several other research firms have also issued reports on CTVA. Wall Street Zen lowered shares of Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Wolfe Research increased their target price on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Wells Fargo & Company increased their target price on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday. Mizuho increased their target price on shares of Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. Finally, Berenberg Bank increased their price objective on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a report on Thursday, March 26th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $84.90.

Corteva Trading Up 0.4%

Corteva stock opened at $79.66 on Wednesday. The firm has a 50 day moving average of $80.00 and a 200 day moving average of $71.49. The firm has a market capitalization of $53.48 billion, a price-to-earnings ratio of 50.41, a P/E/G ratio of 2.72 and a beta of 0.68. Corteva has a 12-month low of $60.53 and a 12-month high of $85.63. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.22. The company had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts predict that Corteva will post 3.62 earnings per share for the current year.

Insider Buying and Selling at Corteva

In related news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.15% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of CTVA. William B. Walkup & Associates Inc. raised its holdings in Corteva by 2.9% in the first quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock worth $373,000 after purchasing an additional 126 shares in the last quarter. AdvisorNet Financial Inc raised its holdings in Corteva by 2.4% in the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock worth $477,000 after purchasing an additional 135 shares in the last quarter. Annis Gardner Whiting Capital Advisors LLC raised its holdings in Corteva by 9.1% in the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 1,674 shares of the company’s stock worth $112,000 after purchasing an additional 140 shares in the last quarter. Tred Avon Family Wealth LLC raised its holdings in Corteva by 2.5% in the first quarter. Tred Avon Family Wealth LLC now owns 6,248 shares of the company’s stock worth $523,000 after purchasing an additional 154 shares in the last quarter. Finally, Drive Wealth Management LLC raised its holdings in Corteva by 3.8% in the fourth quarter. Drive Wealth Management LLC now owns 4,259 shares of the company’s stock worth $285,000 after purchasing an additional 156 shares in the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.